Prognostic Subgroups for Remission and Response in the Coordinated Anxiety Learning and Management (CALM) Trial
Open accessThe DOI matches its Crossref record; 51 of the 51 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: Most patients with anxiety disorders receive treatment in primary care settings. Limited moderator data are available to inform clinicians of likely prognostic outcomes for individual patients. We identify baseline characteristics associated with outcome in adults seeking treatment for anxiety disorders. METHOD: We conducted an exploratory moderator analysis from the Coordinated Anxiety Learning and Management (CALM) trial. In the CALM trial, 1,004 adults who met DSM-IV criteria for generalized anxiety disorder (GAD), panic disorder, social anxiety disorder, and/or posttraumatic stress disorder (PTSD) were randomized to usual care (UC) or a collaborative care intervention (ITV) of cognitive-behavioral therapy and/or pharmacotherapy between June 2006 and April 2008. Logistic regression was used to examine baseline characteristics associated with remission and response overall and by treatment condition. Receiver operating curve (ROC) analyses identified subgroups associated with similar likelihood of response and remission of global anxiety symptoms. Remission was defined as score < 6 on the 12-item Brief Symptom Inventory (BSI-12) anxiety and somatization subscales. Response was defined as at least 50% reduction on BSI-12, or meeting remission criteria. RESULTS: Randomization to ITV over UC was often the strongest predictor of outcome. Several baseline patient characteristics were associated with poor treatment outcome including comorbid depression, increased severity of underlying anxiety disorder(s) (P < .001), low socioeconomic status (perceived [P < .001] and actual [P < .05]), and limited social support (P < .001). Patient characteristics associated with particular benefit from ITV were being female (P < .05), increased depression (P < .01)/GAD severity (P < .05), and low socioeconomic status (P < .05). ROC analysis demonstrated prognostic subgroups with large differences in response likelihood. CONCLUSIONS: Further research should focus on the effectiveness of implementing the ITV intervention of CALM in community treatment centers where patients typically are of low socioeconomic status and may particularly benefit from ITV. TRIAL REGISTRATION: ClinicalTrials.gov identifier: NCT00347269.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Roughly one-third to one-half of patients with SAD do not experience significant clinical benefit from current evidence-based treatment for SAD such as pharmacotherapy with selective serotonin reuptake inhibitors (SSRI) or venlafaxine and cognitive behavioral therapy (CBT) (Kelly et al, 2014;Roy-Byrne et al, 2010;Taylor et al, 2015;Taylor et al, 2017b).”
From Ketamine for Social Anxiety Disorder: A Randomized, Placebo-Controlled Crossover Trial (2018) · cites this paper as Kelly et al, 2014
In the citing paper
“Overall, our findings align with the existing research, indicating that severe anxiety, coexisting depression, and low socioeconomic status are associated with poor outcomes [55].”
From Feasibility of Guided Internet-Based Cognitive Behavioral Therapy for Panic Disorder and Social Anxiety Disorder in Japan: Pilot Single-Arm Trial (2024) · cites this paper as [55]
Citations
Cites
The PHQ-9: Validity of a brief depression severity measure
Kroenke, K., Spitzer, R. L., & Williams, J. B. W. (2001) · Journal of General Internal Medicine · doi:10.1046/j.1525-1497.2001.016009606.x · Cited by 44,910
(1998) · The Journal of Clinical Psychiatry · Cited by 19,139
Kessler, R. C. (1994) · Archives of General Psychiatry · doi:10.1001/archpsyc.1994.03950010008002 · Cited by 12,370
Kessler, R. C., Chiu, W. T., Demler, O., & Walters, E. E. (2005) · Archives of General Psychiatry · doi:10.1001/archpsyc.62.6.617 · Cited by 12,052
(1998) · PubMed · Cited by 10,216
Health inequalities among British civil servants: the Whitehall II study
Marmot, M. G., Stansfeld, S., Patel, C., North, F., Head, J., White, I., Brunner, E., Feeney, A., Marmot, M. G., & Smith, G. D. (1991) · The Lancet · doi:10.1016/0140-6736(91)93068-k · Cited by 3,608
Kessler, R. C., Petukhova, M., Sampson, N. A., Zaslavsky, A. M., & Wittchen, H. (2012) · International Journal of Methods in Psychiatric Research · doi:10.1002/mpr.1359 · Cited by 2,947 · cited 3×
“This secondary analysis of the CALM trial demonstrated: (1) particular characteristics of patients with anxiety disorders associated with poor treatment outcome – comorbid depression, increased severity of underlying anxiety disorder(s), low socioeconomic status (perceived and actual) and limited social support; (2) p…”
BackgroundMethodPrevalence and Treatment of Mental Disorders, 1990 to 2003
Kessler, R. C., Demler, O., Frank, R. G., Olfson, M., Pincus, H. A., Walters, E. E., Wang, P., Wells, K. B., & Zaslavsky, A. M. (2005) · New England Journal of Medicine · doi:10.1056/nejmsa043266 · Cited by 1,910
Socioeconomic Status and Health: What We Know and What We Don't
ADLER, N. E., & OSTROVE, J. M. (1999) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1999.tb08101.x · Cited by 1,643
Psychometric properties of the Social Phobia Inventory (SPIN): New self-rating scale
Connor, K. M., Davidson, J. R. T., Churchill, L. E., Sherwood, A., Weisler, R. H., & Foa, E. (2000) · British Journal of Psychiatry · doi:10.1192/bjp.176.4.379 · Cited by 1,624
Cited by
Kessler, R. C., Sampson, N. A., Berglund, P., Gruber, M. J., Al-Hamzawi, A., Andrade, L., Bunting, B., Demyttenaere, K., Florescu, S., de Girolamo, G., et al. (2015) · Epidemiology and Psychiatric Sciences · doi:10.1017/s2045796015000189 · Cited by 636
“Common causes might also help account for the fact that concurrent comorbidity is associated with poor treatment response for both anxiety disorders (Rapee et al. 2013; Kelly et al. 2014) and MDD (Jakubovski & Bloch, 2014; Saveanu et al. 2014).”
BackgroundKetamine for Social Anxiety Disorder: A Randomized, Placebo-Controlled Crossover Trial
Taylor, J. H., Landeros-Weisenberger, A., Coughlin, C., Mulqueen, J., Johnson, J. A., Gabriel, D., Reed, M. O., Jakubovski, E., & Bloch, M. H. (2018) · Neuropsychopharmacology · doi:10.1038/npp.2017.194 · Cited by 142
Self-citationFinegan, M., Firth, N., Wojnarowski, C., & Delgadillo, J. (2018) · Depression and Anxiety · doi:10.1002/da.22765 · Cited by 123
“…al. (2012) L L U L L L Good Cort et al. (2012) U L H L U L Fair Falconnier (2009) L L U L L L Good Fournier et al. (2009) U L L L L L Good Hoyer et al. (2016) L L L L L L Good Joutsenniemi et al. (2012) L U H H U H Poor Kelly et al. (2015) L L L L L L Good 1Confounding variables not investigated.”
BackgroundInfluentialWho pays the price for high neuroticism? Moderators of longitudinal risks for depression and anxiety
Vittengl, J. R. (2017) · Psychological Medicine · doi:10.1017/s0033291717000253 · Cited by 106
“…treatments for depression and anxiety (e.g. cognitive–behavioral therapy, antidepressant medications) yield lower response rates for patients with lower education, less income, less social support and poorer physical functioning (Jain et al. 2013; Kelly et al. 2015; Stiles-Shields et al. 2015).”
BackgroundTreatment-resistant panic disorder: clinical significance, concept and management
Chen, M., & Tsai, S. (2016) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2016.02.001 · Cited by 80
Taylor, J. H., Lebowitz, E. R., Jakubovski, E., Coughlin, C. G., Silverman, W. K., & Bloch, M. H. (2018) · Journal of Clinical Child & Adolescent Psychology · doi:10.1080/15374416.2017.1371028 · Cited by 63
Self-citationKetamine Effects on EEG during Therapy of Treatment-Resistant Generalized Anxiety and Social Anxiety
Shadli, S. M., Kawe, T. N. J., Martin, D., McNaughton, N., Neehoff, S., & Glue, P. (2018) · The International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyy032 · Cited by 64
“Conventional treatments can take weeks to produce their full effects and, worse, one-third of SAD patients are treatment resistant (Kelly et al., 2015; Taylor et al., 2015, 2018), which increases outpatient costs, doubles hospitalizations, and produces substantial morbidity (Liebowitz et al.”
BackgroundSundermann, B., Bode, J., Lueken, U., Westphal, D., Gerlach, A. L., Straube, B., Wittchen, H.-U., Ströhle, A., Wittmann, A., Konrad, C., et al. (2017) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2017.00099 · Cited by 46
“While there is a clinically significant proportion of non-responders (26, 28, 30), there is only incipient but rapidly increasing knowledge of moderators and predictors of CBT response (12, 31, 32).”
BackgroundFinegan, M., Firth, N., & Delgadillo, J. (2019) · Psychotherapy Research · doi:10.1080/10503307.2019.1649500 · Cited by 47
“…Falconnier, 2009; Kelly, Jakubovski, & Bloch, 2015; Pirkis et al., 2011), and employment (Cort et al., 2012; Delgadillo et al., 2017; El Alaoui et al., 2015; Firth et al., 2015; Kelly et al., 2015; van der Lem, Stamsnieder, van der Wee, van Veen, & Zitman, 2013) as predictors of treatment outcomes.”
BackgroundBarnett, P., Oshinowo, I. D., Cooper, C., Taylor, C. J., Smith, S. M., & Pilling, S. (2022) · Social Psychiatry and Psychiatric Epidemiology · doi:10.1007/s00127-022-02378-9 · Cited by 46
“One low ROB RCT in adults with depression [36] found that patients from lower social classes (classes IV and V) who were treated with either psychotherapy or pharmacotherapy had lower rates of improvement measured on the Hamilton Rating Scale for Depression (b = 0.96, SE = 0.37, p = 0.011) than people from classes III…”
BackgroundInfluentialJakubovski, E., & Bloch, M. H. (2016) · Psychiatric Quarterly · doi:10.1007/s11126-015-9399-6 · Cited by 31
“Analysis on the CALM sample as a whole showed higher predictive effects of depression specifically in the usual care group [9].”
BackgroundMethodSelf-citationBrenes, G. A., Divers, J., Miller, M. E., Anderson, A., Hargis, G., & Danhauer, S. C. (2020) · Depression and Anxiety · doi:10.1002/da.23107 · Cited by 34
“findings are consistent with other interventional studies that found that psychiatric comorbidity (including depression) was associated with improved outcomes in persons receiving CBT and/or collaborative care (Kelly et al., 2015; Newman et al., 2010; Wetherell et al., 2005), but not all (Hundt et al.”
ResultDigital and Mobile Health Technology in Collaborative Behavioral Health Care: Scoping Review
Moon, K. C., Sobolev, M., & Kane, J. M. (2022) · JMIR Mental Health · doi:10.2196/30810 · Cited by 27
“behavioral disorders than is currently feasible in traditional, in-person, provider-administered screening processes [68].”
BackgroundPredictors of anxiety recurrence in the Coordinated Anxiety Learning and Management (CALM) trial
Taylor, J. H., Jakubovski, E., & Bloch, M. H. (2015) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2015.03.020 · Cited by 25
“Our finding compliments a prior analysis of the CALM cohort, which found that for depressed patients and low-income patients, CC was more effective than UC at reducing anxiety (Kelly et al., 2014).”
ResultSelf-citationFoster, S., Mohler‐Kuo, M., Tay, L. S., Hothorn, T., & Seibold, H. (2019) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2019.02.021 · Cited by 17
Bray, R. M., Engel, C. C., Williams, J. G., Jaycox, L. H., Lane, M. E., Morgan, J. K., & Unützer, J. (2016) · Journal of Traumatic Stress · doi:10.1002/jts.22119 · Cited by 16
“, 2014) and all subjects being employed and insured as compared to subjects in both of the other studies (Kelly et al., 2015; Osenbach et al., 2014).”
ResultNeural Circuits Underlying Social Fear in Rodents: An Integrative Computational Model
Alfieri, V., Mattera, A., & Baldassarre, G. (2022) · Frontiers in Systems Neuroscience · doi:10.3389/fnsys.2022.841085 · Cited by 9
“Evidence suggests that pharmacological medications could complement a psychological approach, especially in cases when the severity of the impairment could cause other psychological and health risks, such as depression and suicide attempts (Hambrick et al., 2003; Vitiello, 2009; Kelly et al., 2014; Rao and Andrade, 20…”
BackgroundLedley, D. R., Erwin, B. A., Morrison, A. S., & Heimberg, R. G. (2017) · Wiley eBooks · doi:10.1002/9781394258949.ch2 · Cited by 6
Glutamate Function in Anxiety Disorders and OCD: Evidence from Clinical and Translational Studies
Boff, T. C., Soares, S. J. B., Lima, M. D. M., & Ignácio, Z. M. (2022) · Springer eBooks · doi:10.1007/978-3-030-87480-3_19 · Cited by 5
Treatment-Resistant Panic Disorder
Chen, M., & Tsai, S. (2018) · Springer eBooks · doi:10.1007/978-981-10-4358-1_13 · Cited by 5
Shinno, S., Matsumoto, K., Hamatani, S., Inaba, Y., Ozawa, Y., Kawasaki, Y., Ikai, T., Sutoh, C., Hayashi, H., & Shimizu, E. (2024) · JMIR Formative Research · doi:10.2196/53659 · Cited by 2
“Overall, our findings align with the existing research, indicating that severe anxiety, coexisting depression, and low socioeconomic status are associated with poor outcomes [55].”
ResultUstrup, M., Christensen, T. N., Curth, N. K., Heine, K., Bojesen, A. B., & Eplov, L. F. (2024) · Psychiatric Quarterly · doi:10.1007/s11126-024-10081-y · Cited by 3
“The literature on the impact of anxiety severity at baseline on prognosis also shows contradictory results, which could also be explained by the use of different definitions of the outcome [13, 14, 17–19].”
Linking the Biological Marker Goal-Conflict Specific Rhythmicity (GCSR) and Anxiety Disorder
McNaughton, N., & Glue, P. (2024) · Springer eBooks · doi:10.1007/978-3-031-32035-4_17-1
Linking the Biological Marker Goal-Conflict Specific Rhythmicity (GCSR) and Anxiety Disorder
McNaughton, N., & Glue, P. (2025) · Springer eBooks · doi:10.1007/978-3-031-73368-0_17
Addressing the dual challenge of treatment access and innovation in anxiety disorders
Laposa, J. M., Rowa, K., Soreni, N., & Zai, G. C. (2026) · BMJ · doi:10.1136/bmj.s673
“25”
Metadata
- Authors
- Kelly, J. M., Jakubovski, E., & Bloch, M. H.
- Affiliations
- Yale University (US)
- Connecticut Mental Health Center (US)
- Venue
- The Journal of Clinical Psychiatry
- Publisher
- Physicians Postgraduate Press, Inc
- Published
- 2014-12-09
- Volume
- 76
- Issue
- 03
- Pages
- 267-278
- ISSN
- 0160-6689 (ISSN-L)
- PMC
- PMC4930076
- OpenAlex
- W2000378813
- Cited by
- 25
- References
- 51
- Citations by year
- 2026: 1 · 2025: 1 · 2024: 3 · 2022: 4 · 2020: 1 · 2019: 2 · 2018: 3 · 2017: 5 · 2016: 2 · 2015: 3
- FWCI
- 4.63
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- The Journal of Clinical Psychiatry (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institute of Mental Health (K23MH091240, R25MH077823)
- National Center for Research Resources (UL1RR024139)
- Topics
- Social Sciences › Psychology › Experimental and Cognitive Psychology › Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
- Health Sciences › Medicine › Psychiatry and Mental health › Mental Health Treatment and Access
- Social Sciences › Psychology › Clinical Psychology › Psychotherapy Techniques and Applications
- Keywords
- anxiety disorders, prognostic subgroups, treatment response, remission, collaborative care, cognitive behavioral therapy, pharmacotherapy, generalized anxiety disorder, panic disorder, social anxiety disorder, post-traumatic stress disorder, comorbid depression, socioeconomic status, social support, primary care, moderator analysis
- MeSH terms
- Adolescent, Adult, Aged, Anxiety Disorders, Benzodiazepines, Combined Modality Therapy, Major Depressive Disorder, Female, Humans, Male, Middle Aged, Phobic Disorders, Prognosis, Remission Induction, Severity of Illness Index, Sex Factors, Social Class, Social Support, Stress Disorders, Post-Traumatic, Anti-Anxiety Agents, Cognitive Behavioral Therapy, Panic Disorder, Outcome Assessment, Health Care, Selective Serotonin Reuptake Inhibitors, Adrenergic Uptake Inhibitors, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.